Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 40.75
-0.20 (-0.49%)
Jan 13, 2026, 11:49 AM CST
Center Laboratories Market Cap
Center Laboratories has a market cap or net worth of 30.57 billion as of January 12, 2026. Its market cap has increased by 1.27% in one year.
Market Cap
30.57B
Enterprise Value
33.94B
Revenue
1.57B
Ranking
n/a
PE Ratio
17.99
Stock Price
40.75
Market Cap Chart
Since November 3, 2004, Center Laboratories's market cap has increased from 358.01M to 30.57B, an increase of 8,438.91%. That is a compound annual growth rate of 23.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 30.57B | -1.56% |
| Dec 31, 2025 | 31.06B | -1.69% |
| Dec 31, 2024 | 31.59B | 3.14% |
| Dec 29, 2023 | 30.63B | 8.88% |
| Dec 30, 2022 | 28.13B | -7.93% |
| Dec 30, 2021 | 30.56B | -3.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 228.62B |
| PharmaEssentia | 189.36B |
| Lotus Pharmaceutical | 76.92B |
| Bora Pharmaceuticals Co., LTD. | 64.12B |
| Heron Neutron Medical | 59.70B |
| Oneness Biotech | 33.15B |
| Lumosa Therapeutics | 31.67B |
| Lin BioScience | 30.28B |